Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Navarra
With
Instituto de Salud Carlos III
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Women with primary pathologically confirmed invasive breast adenocarcinoma in stages I, II or IIIA
You may not be if
breast cancer recurrence
in situ CDIS or LDIS
inability or unwillingness to give written informed consent
difficulty to comply with the intervention
lack of willpower to change their diet (using the models of Prochaska and DiClemente)
inability or unwillingness to communicate with study personnel
medical condition that prevents the intervention (digestive disease with fat intolerance; severe psychiatric, neurological or endocrine disease; or allergy or hypersensitivity to any of the key foods of the intervention (EVOO or nuts) or impossibility to follow a Mediterranean diet and/or EVOO intake
immunodeficiency or HIV-positive status
concomitant condition that limits life-expectancy to less than 1 year
difficulty or impossibility for an adequate follow-up
institutionalized patients with lack of autonomy
impossibility for attending group sessions and yearly follow-up visits or for telephone contact
usual alcohol consumption \>80 g/d
BMI\>40
Patients with acute infection or inflammatory process (e.g. pneumonia) may be included in the study three months after the resolution of the infectious symptoms
